Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149
Claim MarketBeat All Access Sale Promotion

Matthew Venezia Analyst Performance

Analyst at Alliance Global Partners

Matthew Venezia is a stock analyst at Alliance Global Partners across a range of sectors, covering 2 publicly traded companies. Over the past year, Matthew Venezia has issued 3 stock ratings, including and buy recommendations. While full access to Matthew Venezia's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Matthew Venezia's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
3 Last 0 Years
Buy Recommendations
100.00% 2 Buy Ratings
Companies Covered
2 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy100.0%2 ratings
Hold0.0%0 ratings
Sell0.0%0 ratings

the majority (100.0%) have been Buy recommendations.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
2 companies

Matthew Venezia, an analyst at Alliance Global Partners, currently covers 2 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Manufacturing
1 company
50.0%
Medical
1 company
50.0%

Matthew Venezia of Alliance Global Partners specializes in stock coverage within the Manufacturing sector, with additional focus on Medical companies.

Coverage Industries

IndustryPercentage
PHARMACEUTICAL PREPARATIONS
1 company
50.0%
MED - BIOMED/GENE
1 company
50.0%

Matthew Venezia's Ratings History at Alliance Global Partners

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Neonc Technologies Holdings, Inc. stock logo
NTHI
Neonc Technologies
5/19/2026Initiated Coverage$5.34$13.00Buy
Pluri Inc. stock logo
PLUR
Pluri
6/2/2025Set Price Target$4.66$12.00
Pluri Inc. stock logo
PLUR
Pluri
6/2/2025Initiated Coverage$4.37$12.00Buy